O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents
about
Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer.An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs).NETs: organ-related epigenetic derangements and potential clinical applications.The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice.Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response.Characteristics of cerebellar glioblastomas in adults.Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study.Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.Management of functional neuroendocrine tumors of the pancreas.O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.Characteristics of H3 K27M-mutant gliomas in adults.
P2860
Q28078610-146957E5-4731-4A11-9057-E5495A69C3CFQ37295241-362047F0-9A72-49DA-B3BB-B85D655D0C12Q38381989-14983036-F7EF-4079-83AB-DA16A49FBBD6Q38835123-AC6EF4C2-EC0B-417B-A885-E7E6BAC46233Q38841735-496CA340-757E-4CC7-BB4A-AEF0FF8309A9Q39448012-9A60F936-295C-4885-9010-D7BDAC7C1A82Q40757352-544167E9-E6AC-4789-A613-BFB027BD0B31Q40853524-B196C390-BD36-4DE4-AFCC-9720C48912EDQ42115029-A0FB4266-EF49-4BCA-9952-644018B3AA72Q47270129-A45C04E2-6E79-4F32-B117-7D211D979D73Q48192532-C7AAC300-5213-4E66-A578-3049ABA26159Q48278842-45201DC1-4BE2-4A98-AB73-A558B4606FD1Q50252299-E5E40A81-3F6B-4ED0-9EE5-AFE1BD25E18DQ52599451-3C381C71-93F8-49D4-8A22-37F719A9400FQ53225327-2F5CDB2D-3EDD-46F2-A00A-6BDEFE3E61CCQ53769248-78755B18-8257-4504-B780-839F8FA7446A
P2860
O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
O6-Methylguanine-DNA methyltra ...... response to alkylating agents
@ast
O6-Methylguanine-DNA methyltra ...... response to alkylating agents
@en
type
label
O6-Methylguanine-DNA methyltra ...... response to alkylating agents
@ast
O6-Methylguanine-DNA methyltra ...... response to alkylating agents
@en
prefLabel
O6-Methylguanine-DNA methyltra ...... response to alkylating agents
@ast
O6-Methylguanine-DNA methyltra ...... response to alkylating agents
@en
P2093
P2860
P356
P1476
O6-Methylguanine-DNA methyltra ...... response to alkylating agents
@en
P2093
B van Brakel
C Lombard-Bohas
C Vercherat
J Forestier
J-A Chayvialle
J-Y Scoazec
P2860
P2888
P304
P356
10.1038/BJC.2014.660
P407
P577
2015-01-13T00:00:00Z
P5875
P6179
1016669191